Is Amazon Proving to be the Wake Up Call Grocers Needed? Here are the Results So Far

It has been just over a year since Amazon acquired Whole Foods for $13.7 billion. The changes were almost immediate, both inside the store, and in the grocery industry. The look of the retail locations began to change right away, with new products available in-store, including items like Amazon devices, and with signage for Amazon Prime deals.

In addition, the retailer cut prices right away and has promised more reductions this November. There has also been a push by the newly owned Whole Foods for new brands coming in nationally instead of the local reliance of the company before the acquisition. In the industry at large, experts agree that the transaction was a wake-up call for grocers everywhere.

In response, grocery store chains have slowed their new store development and instead given more energy to acquiring new technology and/or platforms, as illustrated by Wal-Mart’s purchase of Flipkart and Target’s purchase of Shipt, to name two of the most prominent retailers.

In February, Amazon began testing a grocery delivery program through Whole Foods to four American cities with plans to expand. And more recently, Amazon has begun a new curbside pickup program for Prime Members at some Whole Foods locations. While it is too soon to tell what the long-term impact will be, a recent study by IRI revealed some interesting consumer attitudes.

The survey revealed that 15 percent of shoppers said they are shopping more at the store because of the acquisition, and 61 percent of Whole Foods customers who are also Prime members said that the free delivery options would increase their buying. It added that 71 percent are more satisfied with their shopping experiences and stated they are more likely to keep shopping there as a result. And the number of Prime memberships has risen, possibly in part because of the merger.

Amazon CEO Jeff Bezos claims that the company added more new members in 2017 than in any previous year and more new members on Prime Day 2018 than any other single day since the program began.

Sources:

https://www.cnbc.com/video/2018/06/15/amazon-whole-foods-deal-grocery-anniversary.html

https://progressivegrocer.com/amazon-whole-foods-1-year-later-4-grocery-experts-share-their-insights

https://www.produceretailer.com/article/news-article/irresistible-appeal-prime-study-reveals-amazons-influence-whole-foods-shoppers

https://www.businessinsider.com/amazon-changes-whole-foods-2017-9#amazon-credit-card-holders-now-get-5-cash-back-at-whole-foods-2

https://www.usatoday.com/story/tech/talkingtech/2018/08/08/amazon-starts-new-curbside-pickup-service-whole-foods/926488002/

https://money.cnn.com/2018/04/18/technology/amazon-100-million-prime-members/index.html

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More